Orion Corp. Class B (ORNBV)

Sector:

Medicine and Biotech Research

Index:

OMX Helsinki

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

€  11.15
   
  • 52 Week High: € 13.75
  • 52 Week Low: € 10.37
  • Currency: Euro
  • Shares Issued: 93.18m
  • Market Cap: € 1,038.93m

ORNBV Overview

Orion Corporation is a 45nish company, which develops, manufactures and markets pharmaceuticals. Its products are used to treat diseases of the central nervous system, cardiology, urology, oncology and in critical care. It also provides active pharmaceutical ingredients and diagnostic tests for global markets. The Group operates in Scandinavia, Europe, North America and other countries.

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover 1.1
Op Mrgn 29.9%
ROCE 51.1%
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue 10.2%
PBT 24.0%
EPS 22.4%
DPS 20.0%

ORNBV Fundamentals

Year Ending Revenue (€ m) Pre-tax (€ m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-06 641.10 197.30 110.25¢ 14.9 0.9 +16% 107.04¢ 6.5%
31-Dec-07 680.00 193.40 102.00¢ 15.7 n/a -8% 100.00¢ 6.2%
31-Dec-08 710.70 184.20 97.00¢ 12.4 n/a -5% 100.00¢ 8.3%
31-Dec-09 771.50 203.70 107.00¢ 11.3 1.1 +10% 100.00¢ 8.3%
31-Dec-10 849.90 252.60 131.00¢ n/a n/a +22% 120.00¢ 0.0%

ORNBV Forecasts

ORNBV Forecasts data is not available for this company.

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

ORNBV Market Data

Currency Euro
% Change 0.45 %
52 Week High € 13.75
52 Week Low € 10.37
Shares Issued 93.18m
Market Cap € 1,038.93m

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 3
Sell 3
Strong Sell 4
Total 12
sell
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page